Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Diagnostic Method to Detect Endometriosis

The University of Western Ontario - Industry Liaison
A non-invasive development of a test for the diagnosis and monitoring of endometriosis.

Full description

Novelty

This technology is a non-invasive development of a test for the diagnosis and monitoring of endometriosis.  

Potential Benefits

  • Novel marker levels provide diagnostic for endometriosis and as an indicator of the progression/regression of the disease.
  • The marker may also be a therapeutic target for the treatment and/or prevention or to monitor progression of endometriosis.
  • Useful as an indicator of the aggressiveness of the disease for managing endometriosis.

Description

The endometrium is the tissue that lines the uterus and is normally shed each month during the menstrual cycle. However, in endometriosis, the misplaced endometrium is unable to exit the body and is found to be growing outside the uterus, on or in other areas of the body.

It is a condition which is estimated to affect 90 million women worldwide, representing between 1 and 7% of women in the general population, and up to 30% of those undergoing laparoscopy for chronic pelvic pain are diagnosed with endometriosis.

Therefore, strong demand exists for a fast, accurate, and minimally invasive test for the diagnosis of endometriosis, since current methods involve physical exam., laparoscopy and biopsy, each of which has limitations.

This McMaster inventor has developed novel non-invasive methods, assays and kits for detecting and monitoring the progress of endometriosis.

Development status

Early Stage

Patent information

Development Stage

Test data available. Work is continuing on production of analogues and their optimization.

IP Status

US provisional patent filed. 

Partnering consultation free of charge
EthyPharm
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us